153 related articles for article (PubMed ID: 37850225)
21. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
22. Demineralized Bone Matrix (DBM) as a Bone Void Filler in Lumbar Interbody Fusion: A Prospective Pilot Study of Simultaneous DBM and Autologous Bone Grafts.
Kim BJ; Kim SH; Lee H; Lee SH; Kim WH; Jin SW
J Korean Neurosurg Soc; 2017 Mar; 60(2):225-231. PubMed ID: 28264244
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
24. rhBMP-2 with a demineralized bone matrix scaffold versus autologous iliac crest bone graft for alveolar cleft reconstruction.
Francis CS; Mobin SSN; Lypka MA; Rommer E; Yen S; Urata MM; Hammoudeh JA
Plast Reconstr Surg; 2013 May; 131(5):1107-1115. PubMed ID: 23385986
[TBL] [Abstract][Full Text] [Related]
25. Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2.
Nourian AA; Harrington J; Pulido PA; McCauley JC; Bruffey JD; Eastlack RK
Global Spine J; 2019 Jun; 9(4):398-402. PubMed ID: 31218198
[TBL] [Abstract][Full Text] [Related]
26. Comparative Efficacy of Commonly Available Human Bone Graft Substitutes as Tested for Posterolateral Fusion in an Athymic Rat Model.
Bhamb N; Kanim LEA; Drapeau S; Mohan S; Vasquez E; Shimko D; McKAY W; Bae HW
Int J Spine Surg; 2019 Oct; 13(5):437-458. PubMed ID: 31745449
[TBL] [Abstract][Full Text] [Related]
27. Fusion rate of Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with local bone autograft in posterior lumbar interbody fusion for degenerative lumbar disorders.
Park S; Jeong YH; Ha BJ; Yoo BS; Kim SH; Lee CK; Yi S; Ha Y; Kim KN; Shin DA
Spine J; 2023 Dec; 23(12):1877-1885. PubMed ID: 37516282
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
Parker RM; Malham GM
Eur Spine J; 2017 Mar; 26(3):754-763. PubMed ID: 28028645
[TBL] [Abstract][Full Text] [Related]
29. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
[TBL] [Abstract][Full Text] [Related]
30. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Safety of a 3D-Printed Hydroxyapatite-Demineralized Bone Matrix Scaffold for Spinal Fusion.
Plantz M; Lyons J; Yamaguchi JT; Greene AC; Ellenbogen DJ; Hallman MJ; Shah V; Yun C; Jakus AE; Procissi D; Minardi S; Shah RN; Hsu WK; Hsu EL
Spine (Phila Pa 1976); 2022 Jan; 47(1):82-89. PubMed ID: 34115714
[TBL] [Abstract][Full Text] [Related]
32. Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review.
Liu S; Wang Y; Liang Z; Zhou M; Chen C
Spine (Phila Pa 1976); 2020 Jun; 45(12):E729-E741. PubMed ID: 31923133
[TBL] [Abstract][Full Text] [Related]
33. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
[TBL] [Abstract][Full Text] [Related]
34. PEEK versus titanium cages in lateral lumbar interbody fusion: a comparative analysis of subsidence.
Campbell PG; Cavanaugh DA; Nunley P; Utter PA; Kerr E; Wadhwa R; Stone M
Neurosurg Focus; 2020 Sep; 49(3):E10. PubMed ID: 32871573
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix/P-15 composite.
Mobbs RJ; Maharaj M; Rao PJ
J Neurosurg Spine; 2014 Dec; 21(6):867-76. PubMed ID: 25325176
[TBL] [Abstract][Full Text] [Related]
36. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
37. Minimally Invasive Transforaminal Lumbar Interbody Fusion: Meta-analysis of the Fusion Rates. What is the Optimal Graft Material?
Parajón A; Alimi M; Navarro-Ramirez R; Christos P; Torres-Campa JM; Moriguchi Y; Lang G; Härtl R
Neurosurgery; 2017 Dec; 81(6):958-971. PubMed ID: 28419312
[TBL] [Abstract][Full Text] [Related]
38. Use of Recombinant Human Bone Morphogenetic Protein-2 With Iliac Crest Bone Graft Instead of Iliac Crest Bone Graft Alone in Lumbar Spondylolysis.
Meng H; Gao Y; Zhao G; Sun T; Li F
Clin Spine Surg; 2022 Mar; 35(2):E314-E319. PubMed ID: 34654776
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis.
Keorochana G; Setrkraising K; Woratanarat P; Arirachakaran A; Kongtharvonskul J
Neurosurg Rev; 2018 Jul; 41(3):755-770. PubMed ID: 28013419
[TBL] [Abstract][Full Text] [Related]
40. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
